BioNano Genomics Inc (BNGO) Stock: What Does the Chart Say Monday?

Overall market sentiment has been down on BioNano Genomics Inc (BNGO) stock lately. BNGO receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

BioNano Genomics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BNGO!

See Full BNGO Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BNGO Stock Today?

BioNano Genomics Inc (BNGO) stock is trading at $1.25 as of 10:41 AM on Monday, Nov 13, a decline of -$0.05, or -3.85% from the previous closing price of $1.30. The stock has traded between $1.19 and $1.27 so far today. Volume today is below average. So far 539,690 shares have traded compared to average volume of 928,002 shares.

More About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Click Here to get the full Stock Report for BioNano Genomics Inc stock.